Table 1.
Oxidized phospholipid-apoprotein cross-link adducts identified in HDL3 treated with KOOA-PC
HDL3 (1.5 mg/ml) was incubated with KOOA-PC (10 μm) at 37 °C under the protection of argon. After 4 h incubation, samples were subjected to NaBH4 reduction, tryptic digestion, peptide enrichment, and LC-MS/MS analysis. The MS/MS spectra obtained were searched against a protein sequence database containing major and minor apoproteins of human HDL using Massmatrix search engine to identify oxPL-peptide cross-link adducts as described under “Experimental procedures.”
| HDL apoproteins cross-linked by oxPLs | Cross-linked residues | Peptides cross-linked by oxPLs | na | |
|---|---|---|---|---|
| ApoA-I–apoA-I | AI H135–AI K107 | K$WQEEMELYRQKb | LH$ELQEK | 3 |
| AI H155–AI K106 | AH$VDALRTHLAPYSDELR | VQPYLDDFQK$K | 6 | |
| AI H162–AI K94 | DLEEVK$AKVQPYLDDFQKK | TH$LAPYSDELR | 6 | |
| AI H162–AI K96 | AK$VQPYLDDFQK | TH$LAPYSDELR | 3 | |
| AI H162–AI K106 | AHVDALRTH$LAPYSDELR | VQPYLDDFQK$K | 6 | |
| AI H193–AI K195 | LAEYH$AK$ATEHLSTLSEK | 4 | ||
| AI H199–AI K195 | LAEYHAK$ATEH$LSTLSEK | 6 | ||
| AI H135–AI K182 | QRLAARLEALK$ENGGARLAEYHAK | QKLH$ELQEKLSPLGEEMR | 6 | |
| AI H155–AI K12 | ARAH$VDALRTHLAPYSDELR | VK$DLATVYVDVLK | 4 | |
| AI H199–AI K133 | AELQEGARQK$LHELQEKLSPLGEEMR | ATEH$LSTLSEK | 3 | |
| AI H199–AI K140 | ATEH$LSTLSEK | LHELQEK$LSPLGEEMR | 5 | |
| AI H193–AI K208 | LEALKENGGARLAEYH$AKATEHLSTLSEK | AK$PALEDLR | 4 | |
| ApoA-I–apoA-II | AI H135–AII K46 | AELQEGARQKLH$ELQEKLSPLGEEMR | SYFEKSK$EQLTPLIK | 5 |
| AI H135–AII K30 | AELQEGARQKLH$ELQEKLSPLGEEMR | VK$SPELQAEAK | 4 | |
| AI H155–AII K28 | AH$VDALRTHLAPYSDELRQR | DLMEK$VKSPELQAEAK | 4 | |
| AI H193–AII K46 | SYFEKSK$EQLTPLIK | LAEYH$AK | 5 | |
| Minor apoproteins–apoA-I/apoA-II | AI K140–AIV K73 | QKLHELQEK$LSPLGEEMR | LAK$DSEKLKEEIGK | 6 |
| AI H162–AIV K73 | LAK$DSEKLKEEIGK | TH$LAPYSDELR | 4 | |
| AI H162–apoE K233 | TRDRLDEVK$EQVAEVRAK | TH$LAPYSDELR | 6 | |
| AII K46–AIV K96 | SYFEKSK$EQLTPLIK | LLPH$ANEVSQK | 6 | |
| AII K44–AIV K227 | SYFEK$SKEQLTPLIK | K$NAEELK | 4 | |
| AII K46–apoE K157 | DADDLQK$RLAVYQAGAR | SK$EQLTPLIK | 6 | |
| AI H162–CI K48 | TH$LAPYSDELR | EWFSETFQK$VKEKLK | 3 | |
| AI H162–CI K37 | IKQSELSAK$MREWFSETFQK | TH$LAPYSDELR | 2 | |
| AI K96–CIV K26 | WSLVRGRMK$ELLETVVNR | AK$VQPYLDDFQKK | 3 | |
| AII K30–CIV K81 | DLMEKVK$SPELQAEAK | DSLLK$KTHSLCPR | 3 | |
a n represents number of experiments in which specific cross-link adduct was detected.
b H$ and K$ represent histidine and lysine residues cross-linked by oxPLs. AI, AII, AIV, CI, and CIV represent apoA-I, apoA-II, apoA-IV, apoC-I, and apoC-IV, respectively.